How Low Is Too Low? Characterising Low LDL Cholesterol in a Paediatric Cohort

Background: Low levels of low-density lipoprotein cholesterol (LDL-c) are defined as plasma levels <50 mg/dL or below the 5th percentile. In childhood, low LDL-c might have genetic or acquired causes, however paediatric clinical data remains limited and its clinical significance is not fully understood. This study aimed to characterise clinically, metabolically and genetically a paediatric population with low LDL-c and explore potential causes, differences according to weight status and associated comorbidities.

Methods: A single-centre retrospective observational study was conducted, including children and adolescents aged ≥2 and <18 years with at least one LDL-c measurement <50 mg/dL between 2020 and 2024. Demographic, anthropometric, clinical, biochemical, genetic and follow-up data were reviewed. Metabolic parameters were compared between patients with normal weight and those with overweight or obesity. Analyses were exploratory.

Results: The study included 54 children, of whom 31 (57.4%) were male. Mean age was 10.6 ± 4.1 years and 32 (59.3%) were adolescents. LDL-c values ranged from 6 to 49 mg/dL (mean 39.6 ± 9.9 mg/dL). Among the 19 children with at least two LDL-c measurements, 15 (78.9%) had LDL-c levels <50 mg/dL on at least two separate occasions. Mean BMI z-score was 0.8 ±1.3 and 27 patients (50.0%) had overweight or obesity (at or above the 85th percentile). Compared with normal-weight children, those with overweight/obesity had lower high-density lipoprotein cholesterol (HDL-c) (median 43.0 [IQR 38.5-50.5] vs 48.0 [45.3-58.3] mg/dL; p=0.026), higher triglycerides (52.0 [31.5-79.5] vs 32.5 [27.8-44.3] mg/dL; p=0.029) and higher alanine aminotransferase (ALT) (24.0 [17.5-31.5] vs 16.5 [11.0-20.0] U/L; p=0.001). LDL-c did not differ significantly between groups (42.0 [34.0-46.0] vs 43.5 [38.8-47.3] mg/dL; p=0.384). Low HDL-c and hypertriglyceridaemia were observed in 18.5% and 5.6% of the cohort, respectively. Among patients with available measurements, hyperuricaemia was found in 37.5% (9/24), insulin resistance in 16.0% (4/25) and hepatic steatosis in 14.3% (2/14). Among patients with available ApoB measurements (n=10), LDL-c was strongly correlated with ApoB (r=0.817; p=0.004). A family history of low LDL-c was identified in 7.4% of patients and an APOB variant of uncertain significance was identified in one patient.

Conclusions: In this paediatric cohort with low LDL-c, half of the patients had overweight or obesity. Despite similarly low LDL-c levels, children with overweight or obesity showed less favourable metabolic profile (lower HDL-c and higher triglyceride and ALT levels) than normal-weight children. Low LDL-c persisted on repeat testing in 15 of 19 (78.9%) retested patients. These findings highlight that low LDL-c should not be interpreted as indicating a uniformly favourable metabolic profile itself. Given the retrospective design and incomplete metabolic and genetic assessment, prospective longitudinal studies are needed to better define the natural history, aetiology, clinical significance and long-term metabolic and cardiovascular implications of low LDL-c in children and adolescents.